King Vision Video Laryngoscope aBlade vs. Direct Laryngoscopy in Children
Launched by ANN & ROBERT H LURIE CHILDREN'S HOSPITAL OF CHICAGO · Mar 4, 2015
Trial Information
Current as of May 11, 2025
Unknown status
Keywords
ClinConnect Summary
The goal of this prospective randomized study is to compare whether there is a clinically relevant difference in the rate of first attempt successful intubation between the Ambu King Vision Video Laryngoscope and direct laryngoscopy using the Miller Blade Laryngoscope. Other parameters of clinical relevance such as grade of laryngeal view, percentage of glottic opening, number of insertion attempts, time for successful tracheal intubation, and complications will also be assessed.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA (American Society of Anesthesiologists) I-III classified patients
- • Patients undergoing procedure where an endotracheal tube would be normally utilized
- Exclusion Criteria:
- • Children with expected difficult airways
- • Coagulopathy
About Ann & Robert H Lurie Children's Hospital Of Chicago
Ann & Robert H. Lurie Children's Hospital of Chicago is a leading pediatric healthcare institution dedicated to advancing child health through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital focuses on developing and evaluating novel therapies and treatments tailored for children. With a commitment to evidence-based practices and a multidisciplinary approach, Lurie Children's collaborates with various stakeholders to enhance pediatric care and improve health outcomes for children locally and globally. Through its robust research programs, the hospital aims to transform pediatric medicine and address the unique challenges faced by young patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
narasimhan jagannathan, MD
Principal Investigator
Ann & Robert Lurie Children's Hospital of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials